Heart Failure Clinical Trial
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
Summary
Observational study of elderly individuals diagnosed with Non-Valvular Atrial Fibrillation and Heart Failure who are beginning oral blood thinners
Eligibility Criteria
Inclusion Criteria:
Were age greater than or equal to 65 years as of the index date
Had greater than or equal to 1 diagnosis of AF prior to or on the index date
Had greater than or equal to 1 diagnosis claim of HF during the 12 months prior to or on the index date
Had 1 or more pharmacy claim for oral blood thinners
Exclusion Criteria:
Claims indicating diagnosis or procedure for hip/knee replacement surgery within 6 weeks prior to index date
Pharmacy claim for warfarin, apixaban, dabigatran, edoxaban or rivaroxaban during the 12-month baseline period
Greater than 1 oral anticoagulants prescription claim on the index date and/or with a follow-up less than 1 day
Had medical claim indicating VTE in the 12 months prior to index date
Other protocol defined inclusion/exclusion criteria could apply
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Ann Arbor Michigan, 48104, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.